An experimental agent has shown promising results in people with advanced biliary cancer, according new research. The agent, known as AZD6244, blocks enzymes cancer cells need to proliferate and survive.
Full article >>
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment